Applied Sciences Homework

Hide Assignment Information

Turnitin™

This assignment will be submitted to Turnitin™.

Instructions

CTA Prototype Assignment Weight: 20% of Final Grade

As discussed in class, in order for a clinical trial to be conducted in Canada, a Clinical Trial Application must be filed and approved by Health Canada before it can begin. As a regulatory affairs associate working for a large multinational pharmaceutical company, you have been asked to prepare a CTA for a new oncology product named “Sheridanumab”. The proposed study is for “An Open-label, Multicenter, Single-arm, Phase II Study of Sheridanumab in Patients with Germline BRCA1/2 Mutation and Platinum-sensitive Recurrent Ovarian Cancer”. You have previously held a pre-CTA meeting with Health Canada and have been given the green light to proceed with a CTA.

1. Create a prototype of your CTA, listing all relevant documents that you would need to file and what CTD section it would go in. If a CTA section does not apply, please indicate N/A. Please organize your Modules using the following tabular format:

2. Indicate what guidance document(s) you used to determine how to build your CTA prototype.

3. Summarize the differences between a CTA and IND.

General Instructions: • The Prototype project should follow the APA format with font size 12 and 1.5 spacing, Times New Roman. • Provide each question and your response following it. Include all references. • A title page should be included in addition to the page limit. The title page should contain informtion such as Student Name, Student ID, Prototype title, course code etc. • The marking rubric is atached for your reference.